Gurnet Point Capital invests in companies with scientifically de-risked life science products, aiming to bring safe and effective treatments to market, impacting patient outcomes and generating investor returns.
invested in
competitor of
Metrics
marketPRIVATE
msh_idCOM:GURNETPOINTCAPITAL
localeus
websitehttps://www.gurnetpointcapital.com/
source_ref462ca3c4-a9bd-451d-86ed-a74dee2a98f3
products_or_servicesInvestment in life science companies
United States